Montreal Cognitive Assessment (MoCA)
Screens for mild cognitive impairment.
Neurology
106 entries · Page 3 of 4
M
N
New Orleans/Charity Head Trauma/Injury Rule
Criteria for which patients are unlikely to require imaging after head trauma.
NEXUS Criteria for C-Spine Imaging
Clears patients from cervical spine fracture clinically, without imaging.
NIH Stroke Scale/Score (NIHSS)
Quantifies stroke severity and monitors for neurological changes over time.
NINCDS-ADRDA Criteria for Alzheimer’s Disease
Diagnoses Alzheimer disease (AD), alternative to IWG-2 Criteria .
O
OESIL Score for Syncope
Estimates 12-month all-cause mortality in patients presenting with syncope.
Ottawa Subarachnoid Hemorrhage (SAH) Rule for Headache Evaluation
Rules out SAH in patients with headache.
Overall Neuropathy Limitations Scale (ONLS)
Quantifies severity of peripheral neuropathy.
Oxcarbazepine Pediatric Dose — Anticonvulsant
Oxcarbazepine pediatric dose: 4–5 mg/kg/dose PO every 12 hours as an initial starting dose for seizure management in children.
P
Pain Assessment in Advanced Dementia Scale (PAINAD)
Assesses pain in patients with dementia.
Palchak (UC Davis) Rule for Pediatric Head Trauma
Identifies children at low risk for brain injuries after blunt head trauma.
PECARN Pediatric Head Injury/Trauma Algorithm
Predicts need for brain imaging after pediatric head injury.
Pediatric Glasgow Coma Scale (pGCS)
Assesses impaired consciousness and coma in pediatric patients.
Pediatric NEXUS II Head CT Decision Instrument for Blunt Trauma
Predicts need for head CT after pediatric blunt head injury, similar to PECARN .
Pediatric NIH Stroke Scale (NIHSS)
Quantifies stroke severity using a child-specific version of the NIH Stroke Score .
Phenytoin (Dilantin) Correction for Albumin/Renal Failure
Corrects serum phenytoin level for renal failure and/or hypoalbuminemia.
Phenytoin Pediatric Dose — Anticonvulsant
Evidence-based phenytoin pediatric dose guide covering IV loading and maintenance dosing for seizure management in neonates, infants, and children.
Pittsburgh Response to Endovascular therapy (PRE) Score
Identifies patients with anterior circulation large vessel occlusion (LVO) strokes likely to benefit from endovascular therapy.
PLAN Score for Stroke
Predicts mortality and severe disability in acute ischemic stroke.
R
Rapid Arterial oCclusion Evaluation (RACE) Scale for Stroke
Predicts large vessel occlusion (LVO) in patients with acute stroke.
Recognition of Stroke in the Emergency Room (ROSIER) Scale
Distinguishes between acute stroke and stroke mimics.
Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R)
Stratifies severity of amyotrophic lateral sclerosis (ALS), including respiratory function.
Revised McDonald Criteria for Multiple Sclerosis Diagnosis
Determines presence of MS using MRI findings.
Richmond Agitation-Sedation Scale (RASS)
Ranks agitation and possibility for sedation.
Risk of Paradoxical Embolism (RoPE) Score
Identifies stroke-related PFO in patients with cryptogenic stroke.
ROSE (Risk Stratification of Syncope in the Emergency Department) Rule
Predicts 1-month serious outcome or death in patients presenting with syncope.
S
San Francisco Syncope Rule
Predicts risk for serious outcomes at 7 days in patients presenting with syncope or near-syncope.
Schwab and England Activities of Daily Living (ADL) Scale
Grades functional status in patients with Parkinson’s disease.
Secondary Intracerebral Hemorrhage (sICH) Score
Quantifies likelihood of underlying vascular etiology in patients with ICH.
No entries match your filter.